APLS
Apellis Pharmaceuticals Inc.
$25.23
+$0.27(+1.06%)
52
Overall
40
Value
66
Tech
50
Quality
Market Cap
$3.01B
Volume
1.58M
52W Range
$16.10 - $35.71
Target Price
$35.39
Key Metrics Overview
| Market Cap | $3.01B | P/E Ratio | 105.13 |
| 52W High | $35.71 | 52W Low | $16.10 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 43.4% | 52W Position | 46.6% |
| Overall Score | 52 | Value Score | 40 |
| Quality Score | 50 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $0.24 | EPS Next Est | $-1.22 |
| EPS Growth Est | -608.3% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $25.23 | +1.1% | 1.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW